U.S. Approves Molnupiravir, 2nd COVID Treatment Pill From Merck
The FDA approved Pfizer's COVID pill Wednesday for high-risk patients.
Full Article
U.S. Approves Molnupiravir, 2nd COVID Treatment Pill From Merck
CBS 2
0 shares
1 views
You might like
Related news coverage
Pfizer antiviral pill could be risky with other widely used medications
PIX 11
The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the..
-
New COVID treatment pills not for everyone, need to be taken as soon as possible
euronews
-
Two new COVID treatment pills: who can take them and when?
euronews
-
EXPLAINER: New easy-to-use COVID-19 pills come with a catch
SeattlePI.com
-
EXPLAINER: What COVID-19 therapies are available in US?
SeattlePI.com
Advertisement
More coverage
Merck's COVID-19 pill to arrive in Israel within two weeks
Jerusalem Post
Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus..
-
Live updates: Japan approves use of Merck's COVID-19 pill
SeattlePI.com
-
After Pfizer, US grants emergency use authorization for Merck's COVID-19 pill
DNA
-
FDA authorizes a 2nd easy-to-use COVID treatment, Merck's antiviral pill
NPR
-
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adults
NYTimes.com